{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:07:30Z","timestamp":1780117650774,"version":"3.54.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.diagmicrobio.2016.11.003","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T07:31:51Z","timestamp":1478935911000},"page":"163-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Gary P.","family":"Wormser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc","family":"Strle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Dattwyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Auwaerter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0005","author":"Administration on aging: aging statistics"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.idc.2015.02.004","article-title":"Diagnosis and treatment of Lyme arthritis","volume":"29","author":"Avikar","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0015","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1212\/WNL.43.12.2609","article-title":"Neurologic manifestations in children with North American Lyme disease","volume":"43","author":"Belman","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0020","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ene.12420","article-title":"Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension","volume":"21","author":"Bremell","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0025","first-page":"590","article-title":"Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease","volume":"44","author":"Centers for Disease Control and Prevention (CDC)","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0030","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1288\/00005537-198511000-00009","article-title":"Facial paralysis in Lyme disease","volume":"95","author":"Clark","year":"1985","journal-title":"Laryngoscope"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0035","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/167.2.392","article-title":"Western blotting in the serodiagnosis of Lyme disease","volume":"167","author":"Dressler","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ana.410410313","article-title":"Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease","volume":"41","author":"England","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/01.wnl.0000336370.51010.a1","volume":"72","author":"England","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0050","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0733-8619(05)70166-3","article-title":"Spirochetal infection of the nervous system","volume":"17","author":"Estanislao","year":"1999","journal-title":"Neurol Clin"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0055","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0060","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM199610243351703","article-title":"For the pediatric Lyme disease study group. Lyme disease in children in southeastern Connecticut","volume":"335","author":"Gerber","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.idc.2015.02.002","article-title":"Nervous system Lyme disease","volume":"29","author":"Halperin","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0070","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1212\/WNL.37.11.1700","article-title":"Lyme disease: cause of a treatable peripheral neuropathy","volume":"37","author":"Halperin","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0075","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/brain\/113.4.1207","article-title":"Lyme neuroborreliosis. Peripheral nervous system manifestations","volume":"113","author":"Halperin","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice parameter: treatment of nervous system Lyme disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/B978-0-444-52902-2.00032-1","article-title":"Lyme neuroborreliosis","volume":"115","author":"Hansen","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-9343(99)00046-7","article-title":"Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the Northeast United States","volume":"106","author":"Hilton","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0095","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0100","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jnnp.38.5.452","article-title":"Peripheral neuropathy in acrodermatitis chronic atrophicans (Herxheimer)","volume":"38","author":"Hopf","year":"1975","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/jnnp-2012-302312","article-title":"Biology of the blood-nerve barrier and its alteration in immune-mediated neuropathies","volume":"84","author":"Kanda","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0404.1997.tb00222.x","article-title":"Peripheral neuropathy in acrodermatitis chronica atrophicans\u2014a late borrelia manifestation","volume":"95","author":"Kindstrand","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0404.2000.00019.x","article-title":"Polyneuropathy in late Lyme borreliosis\u2014a clinical, neurophysiological and morphological description","volume":"101","author":"Kindstrand","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1600-0404.2002.01336.x","article-title":"Peripheral neuropathy in acrodermatitis chronica atrophicans\u2014effect of treatment","volume":"106","author":"Kindstrand","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0125","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.1996.03530450047031","article-title":"Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness","volume":"275","author":"Krause","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3201\/eid2007.131587","article-title":"Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the Northeastern United States","volume":"20","author":"Krause","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.1988.tb31836.x","article-title":"Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features","volume":"539","author":"Kristoferitsch","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0140","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial","volume":"7","author":"Ljostad","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1212\/WNL.42.2.303","article-title":"Clinical and electrophysiological findings in chronic neuropathy of Lyme disease","volume":"42","author":"Logigian","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0150","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0155","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1468-1331.2006.01395.x","article-title":"Chronic polyneuropathy and Lyme disease","volume":"13","author":"Mygland","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"European Federation of Neurological Societies EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0165","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3201\/eid2109.150417","article-title":"Incidence of clinician-diagnosed Lyme disease, United States, 2005\u20132010","volume":"21","author":"Nelson","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0170","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciw299","article-title":"Course and outcome of early European Lyme neuroborreliosis (Bannwarth's syndrome)\u2014clinical and laboratory findings","volume":"63","author":"Ogrinc","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1034\/j.1600-065x.2001.1830115.x","article-title":"The rhesus model of Lyme neuroborreliosis","volume":"183","author":"Pachner","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0180","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(15)00464-8","article-title":"Identification of a novel pathogenic borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study","volume":"16","author":"Pritt","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0185","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/515357","article-title":"Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system","volume":"178","author":"Roberts","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0190","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"279","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0195","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.1780370616","article-title":"Treatment of Lyme arthritis","volume":"37","author":"Steere","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000353293","article-title":"The molecular and biophysical characterization of the human blood-nerve barrier: Current concepts","volume":"50","author":"Ubogu","year":"2013","journal-title":"J Vasc Res"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0210","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.mayocp.2015.05.004","article-title":"Peripheral neuropathy: a practical approach to diagnosis and symptom management","volume":"90","author":"Watson","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0215","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.09.003","article-title":"Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease","volume":"75","author":"Wormser","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0225","series-title":"Management approaches for suspected and established Lyme disease used at the Lyme disease diagnostic center","author":"Wormser","year":"2016"},{"key":"10.1016\/j.diagmicrobio.2016.11.003_bb0230","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-114-4-285","article-title":"Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease","volume":"114","author":"Zoschke","year":"1991","journal-title":"Ann Intern Med"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316303741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316303741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:01:57Z","timestamp":1718895717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889316303741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0732889316303741"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.11.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}